Alexander D McLellan, Seyed M Ali Hosseini Rad. Immunol Cell Biol 2019
Times Cited: 98
Times Cited: 98
G Gross, T Waks, Z Eshhar. Proc Natl Acad Sci U S A 1989
Times Cited: 896
Times Cited: 896
List of shared articles
Times cited
CAR T cell therapy in solid tumors; with an extensive focus on obstacles and strategies to overcome the challenges.
Ayda Baghery Saghchy Khorasani, Mohammad-Javad Sanaei, Atieh Pourbagheri-Sigaroodi, Seyed H Ghaffari, Davood Bashash. Int Immunopharmacol 2021
Ayda Baghery Saghchy Khorasani, Mohammad-Javad Sanaei, Atieh Pourbagheri-Sigaroodi, Seyed H Ghaffari, Davood Bashash. Int Immunopharmacol 2021
Chimeric antigen receptor T-cell therapies: Optimising the dose.
Nathaniel Dasyam, Philip George, Robert Weinkove. Br J Clin Pharmacol 2020
Nathaniel Dasyam, Philip George, Robert Weinkove. Br J Clin Pharmacol 2020
The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers.
Lara Herrera, Silvia Santos, Miguel Angel Vesga, Tomas Carrascosa, Juan Carlos Garcia-Ruiz, Antonio Pérez-Martínez, Manel Juan, Cristina Eguizabal. Cancers (Basel) 2021
Lara Herrera, Silvia Santos, Miguel Angel Vesga, Tomas Carrascosa, Juan Carlos Garcia-Ruiz, Antonio Pérez-Martínez, Manel Juan, Cristina Eguizabal. Cancers (Basel) 2021
Global Perspective on the Development of Genetically Modified Immune Cells for Cancer Therapy.
Laetitia Pinte, Amy Cunningham, Helene Trébéden-Negre, Sarah Nikiforow, Jerome Ritz. Front Immunol 2021
Laetitia Pinte, Amy Cunningham, Helene Trébéden-Negre, Sarah Nikiforow, Jerome Ritz. Front Immunol 2021
The Application of CAR-T Cells in Haematological Malignancies.
Katarzyna Skorka, Katarzyna Ostapinska, Aneta Malesa, Krzysztof Giannopoulos. Arch Immunol Ther Exp (Warsz) 2020
Katarzyna Skorka, Katarzyna Ostapinska, Aneta Malesa, Krzysztof Giannopoulos. Arch Immunol Ther Exp (Warsz) 2020
BCMA-targeting chimeric antigen receptor T-cell therapy for multiple myeloma.
Jinrong Yang, Weilin Zhou, Dan Li, Ting Niu, Wei Wang. Cancer Lett 2023
Jinrong Yang, Weilin Zhou, Dan Li, Ting Niu, Wei Wang. Cancer Lett 2023
CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Armando Camacho, Cesar Ramírez-Segura. Front Immunol 2022
Gina López-Cantillo, Claudia Urueña, Bernardo Armando Camacho, Cesar Ramírez-Segura. Front Immunol 2022
Exhaustion of CAR T cells: potential causes and solutions.
Taku Kouro, Hidetomo Himuro, Tetsuro Sasada. J Transl Med 2022
Taku Kouro, Hidetomo Himuro, Tetsuro Sasada. J Transl Med 2022
Chimeric antigen receptor engineered T cells and their application in the immunotherapy of solid tumours.
Rui Mao, Mohamed S Hussein, Yukai He. Expert Rev Mol Med 2022
Rui Mao, Mohamed S Hussein, Yukai He. Expert Rev Mol Med 2022
Better by design: What to expect from novel CAR-engineered cell therapies?
Vera Luginbuehl, Eytan Abraham, Karin Kovar, Richard Flaaten, Antonia M S Müller. Biotechnol Adv 2022
Vera Luginbuehl, Eytan Abraham, Karin Kovar, Richard Flaaten, Antonia M S Müller. Biotechnol Adv 2022
CAR-T therapy: Prospects in targeting cancer stem cells.
Xiaoyue Cui, Rui Liu, Lian Duan, Dan Cao, Qiaoling Zhang, Aijie Zhang. J Cell Mol Med 2021
Xiaoyue Cui, Rui Liu, Lian Duan, Dan Cao, Qiaoling Zhang, Aijie Zhang. J Cell Mol Med 2021
Improving CAR T-Cell Persistence.
Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang, Francesco Marincola. Int J Mol Sci 2021
Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang, Francesco Marincola. Int J Mol Sci 2021
Immune Modulation in Lung Cancer: Current Concepts and Future Strategies.
Lena Gaissmaier, Petros Christopoulos. Respiration 2020
Lena Gaissmaier, Petros Christopoulos. Respiration 2020